Gene · 23091
Papers1,599
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,599
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High FAAP24 expression reveals poor prognosis and an immunosuppressive microenvironment shaping in AML. | Cancer Cell Int | 2023 | 37328842 | PubTator, text mining | PubMed |
| m6A reader proteins: the executive factors in modulating viral replication and host immune response. | Front Cell Infect Microbiol | 2023 | 37325513 | PubTator, text mining | PubMed |
| Cross-talk of RNA modification "writers" describes tumor stemness and microenvironment and guides personalized immunotherapy for gastric cancer. | Aging (Albany NY) | 2023 | 37319315 | PubTator, text mining | PubMed |
| Splicing factor TRA2A contributes to esophageal cancer progression via a noncanonical role in lncRNA m6 A methylation. | Cancer Sci | 2023 | 37317053 | PubTator, text mining | PubMed |
| N6-methyladenosine is required for efficient RNA synthesis of Ebola virus and other haemorrhagic fever viruses. | Emerg Microbes Infect | 2023 | 37306620 | PubTator, text mining | PubMed |
| A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma. | Transl Cancer Res | 2023 | 37304536 | PubTator, text mining | PubMed |
| A spliceosome-associated gene signature aids in predicting prognosis and tumor microenvironment of hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37301543 | PubTator, text mining | PubMed |
| Targeting IGF2BP3 in Cancer. | Int J Mol Sci | 2023 | 37298373 | PubTator, text mining | PubMed |
| The Emerging, Multifaceted Role of WTAP in Cancer and Cancer Therapeutics. | Cancers (Basel) | 2023 | 37297015 | PubTator, text mining | PubMed |
| The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression. | Front Pharmacol | 2023 | 37284313 | PubTator, text mining | PubMed |
| The Role of RNA Methylation Modification Related Genes in Prognosis and Immunotherapy of Colorectal Cancer. | Int J Gen Med | 2023 | 37284034 | PubTator, text mining | PubMed |
| Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential. | Biomark Res | 2023 | 37280679 | PubTator, text mining | PubMed |
| Tumor-associated macrophages promote cisplatin resistance in ovarian cancer cells by enhancing WTAP-mediated N6-methyladenosine RNA methylation via the CXCL16/CXCR6 axis. | Cancer Chemother Pharmacol | 2023 | 37272931 | PubTator, text mining | PubMed |
| METTL3-dependent m6A methylation facilitates uterine receptivity and female fertility via balancing estrogen and progesterone signaling. | Cell Death Dis | 2023 | 37270544 | PubTator, text mining | PubMed |
| The role of m6A methylation in therapy resistance in cancer. | Mol Cancer | 2023 | 37264402 | PubTator, text mining | PubMed |
| An N6-methyladenosine regulation- and mRNAsi-related prognostic index reveals the distinct immune microenvironment and immunotherapy responses in lower-grade glioma. | BMC Bioinformatics | 2023 | 37264314 | PubTator, text mining | PubMed |
| RBM33 is a unique m6A RNA-binding protein that regulates ALKBH5 demethylase activity and substrate selectivity. | Mol Cell | 2023 | 37257451 | PubTator, text mining | PubMed |
| m6A Regulator-mediated RNA Methylation Modulates Immune Microenvironment of Hepatitis B Virus-related Acute Liver Failure. | Inflammation | 2023 | 37256461 | PubTator, text mining | PubMed |
| Integrating machine learning and bioinformatics analysis to m6A regulator-mediated methylation modification models for predicting glioblastoma patients' prognosis and immunotherapy response. | Aging (Albany NY) | 2023 | 37244287 | PubTator, text mining | PubMed |
| IL5RA as an immunogenic cell death-related predictor in progression and therapeutic response of multiple myeloma. | Sci Rep | 2023 | 37236993 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23091/papers?page=14